Abstract
P30-1 Comparison of efficacy of atezolizumab and bevacizumab treatment for hepatocellular carcinoma between tyrosine kinase inhibitor-naive and -experienced patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have